Skip to main content
profile image
Selected Works of Steven A. Vasilev, MD
Article
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer
Bone Marrow Transplantation (2001)
  • Rj Morgan, City of Hope National Medical Center
  • Jh Doroshow, City of Hope National Medical Center
  • L Leong, City of Hope National Medical Center
  • J Schriber, City of Hope National Medical Center
  • S Shibata, City of Hope National Medical Center
  • S Forman, City of Hope National Medical Center
  • V Hamasaki, City of Hope National Medical Center
  • K Margolin, City of Hope National Medical Center
  • G Somlo, City of Hope National Medical Center
  • J Alvarnas, City of Hope National Medical Center
  • M McNamara, City of Hope National Medical Center
  • J Longmate, City of Hope National Medical Center
  • J Raschko, City of Hope National Medical Center
  • W Chow, City of Hope National Medical Center
  • S Vasilev, City of Hope National Medical Center
  • K McGonigle, City of Hope National Medical Center
  • Y Yen, City of Hope National Medical Center
Link
Disciplines
Publication Date
November 1, 2001
DOI
10.1038/sj.bmt.1703243
Citation Information
Rj Morgan, Jh Doroshow, L Leong, J Schriber, et al.. "Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer" Bone Marrow Transplantation Vol. 28 Iss. 9 (2001) p. 859 - 863
Available at: http://works.bepress.com/steven-vasilev/15/